Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, the upper arm is one of three licensed injection sites for Mounjaro (tirzepatide). The Mounjaro SmPC, published on the electronic Medicines Compendium, confirms that subcutaneous injections may be given in the abdomen, thigh or upper arm, and that rotating between these sites is recommended each week. As a prescription-only medicine, Mounjaro requires clinical assessment before it can be supplied — a prescriber decides both suitability and the injection guidance that fits your situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC, the definitive reference for how the medicine is used, lists the upper arm alongside the abdomen and thigh as suitable subcutaneous injection sites. The guidance on the eMC does not rank these sites or recommend one over another, what it emphasises is rotating the injection point each week. Giving every dose in the same spot can cause the skin and underlying tissue to change over time, which may affect absorption. That means if you used your abdomen last week, your arm or thigh this week is the right call, and you should also shift the exact spot within whichever area you choose.
The subcutaneous layer (the soft fatty tissue between skin and muscle) is thinner over the upper arm than over the abdomen in many people. Getting the angle right matters. A shallow pinch of skin, needle inserted at roughly a 90-degree angle for most adults, keeps the medicine where it needs to go. If the layer is very thin, your prescriber or the Patient Information Leaflet may suggest a slightly angled approach; that is a conversation for your clinical team, not something to adjust based on a forum recommendation.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults and found average weight reductions of around 20–21% at the highest dose over 72 weeks. Those results were achieved across participants using all three licensed sites, which reinforces that the site itself is not the variable determining outcomes, consistency of dosing and rotation are.
The abdomen is straightforward to reach. The thigh is easy enough with a bit of practice. The back of the upper arm (the typical injection zone, where there is usually more subcutaneous tissue than the inner or front surface) is genuinely awkward to do on your own. Reaching round with your dominant hand, pinching the skin, and pressing the KwikPen's button in a controlled way all at once takes some coordination.
A lot of people find a rhythm that works for them: using the thigh on days they are injecting alone, and asking a partner or family member to help with the arm on the day that suits the weekly schedule best. If your injection day is a Thursday morning before the school run, lining up help for that window is easier once it becomes routine. Neither approach is wrong, the clinical priority is that the dose goes in correctly and the site rotates.
Some people find using a mirror helps with arm placement; others prefer to feel for the soft area on the back of the arm (roughly mid-point between shoulder and elbow, away from the inner surface) and go by touch. The KwikPen is designed so the needle retracts automatically after use, which reduces one common worry about self-injection. Our full guide to injecting Mounjaro in the arm walks through every step, and full instructions are also in the Patient Information Leaflet inside your Mounjaro packaging.
If you are unsure about your technique, the team at nume's pharmacy (sorry, at nume's pharmacy) can advise; or speak directly with your prescriber. Questions about specific technique are exactly what aftercare is for.
Localised reactions at the injection site (redness, mild bruising, a small lump, or brief discomfort) are among the more common side effects listed for Mounjaro and are not specific to the arm. The NHS medicines page for tirzepatide notes that these reactions are usually mild and settle quickly. Rotating sites reduces the chance of repeated local irritation building into something more persistent.
Cleaning the chosen area with an alcohol swab before injecting is standard practice. Let the skin dry fully before inserting the needle; injecting through wet skin can sting more and may introduce traces of alcohol under the skin. If you notice a site reaction that does not settle within a few days, develops significant swelling, warmth or discharge, or if you experience any symptoms beyond the local area, contact your prescriber or a healthcare professional.
The broader side-effect profile of Mounjaro is predominantly gastrointestinal (nausea, loose stools, indigestion and reduced appetite are the most commonly reported) and these are not site-dependent. They tend to be most noticeable after starting treatment or after a dose increase, and they generally ease as the body adjusts. Your prescriber will have discussed these at the clinical review stage; your Patient Information Leaflet covers them in full.
There is no single correct answer to which site to use. Clinical guidance points to rotation as the principle, and personal practicality determines the pattern within that. People with less abdominal subcutaneous tissue sometimes find the thigh or arm more comfortable. If you are weighing up whether you can inject Mounjaro in the arm given your own build and circumstances, that page sets out the practical and clinical considerations in detail; increased local blood flow from heavy exercise can theoretically alter absorption too, again, something to raise with your prescriber rather than adjust unilaterally.
For a fuller look at everything involved in the Mounjaro injection process, the general Mounjaro injection guide covers preparation, storage and the KwikPen mechanism in one place. If you are new to treatment and thinking about whether it is right for you, the Mounjaro treatment overview sets out what the medicine is, who it is licensed for and what to expect. Information on how arm sites compare in practice is also covered in more detail at our arm injection sites page and at the specific upper-arm site guide.
If you are considering starting Mounjaro and want a prescriber to assess your suitability, check your eligibility with our clinical team, consultations are free, and a GPhC-registered prescriber reviews every application the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.